527PDTrastuzumab and tucatinib for the treatment of HER2...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

527PDTrastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial

Strickler, J H, Zemla, T, Ou, F-S, Cercek, A, Wu, C, Sanchez, F A, Hubbard, J, Jaszewski, B, Bandel, L, Schweitzer, B, Niedzwiecki, D, Kemeny, N, Boland, P M, Ng, K, Bekaii-Saab, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz246.005
Date:
October, 2019
File:
PDF, 76 KB
2019
Conversion to is in progress
Conversion to is failed